These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Immunotherapy of cancer with BCG]. Yamamura Y; Azuma I Nihon Rinsho; 1974 Mar; 32(3):542-53. PubMed ID: 4603604 [No Abstract] [Full Text] [Related]
4. Use of BCG in the treatment of human neoplasms: a review. Nathanson L Semin Oncol; 1974 Dec; 1(4):337-50. PubMed ID: 4620439 [No Abstract] [Full Text] [Related]
5. Immunotherapy for malignant disease. Med Lett Drugs Ther; 1976 Sep; 18(20):83-4. PubMed ID: 1066519 [No Abstract] [Full Text] [Related]
6. Immunotherapy and chemoimmunotherapy of malignant disease with BCG and nonviable mycobacterial fractions. Schwarz MA; Gutterman JU; Hersh EM; Richman SP; Mavligit GM World J Surg; 1977 Sep; 1(5):555-83. PubMed ID: 272083 [No Abstract] [Full Text] [Related]
7. Immunotherapy in the management of myelogenous leukemia. Fairley GH Arch Intern Med; 1976 Dec; 136(12):1406-12. PubMed ID: 793553 [TBL] [Abstract][Full Text] [Related]
8. Critical review of previously reported clinical trials of cancer immunotherapy with nonspecific immunostimulants. Mastrangelo MJ; Berd D; Bellet RE Ann N Y Acad Sci; 1976; 277(00):94-123. PubMed ID: 793490 [No Abstract] [Full Text] [Related]
9. [Immunotherapy of cancer: evolution of concepts and clinical advances]. Baldwin RW Rev Prat; 1980 Jan; 30(5):221-4, 227-8. PubMed ID: 6929557 [No Abstract] [Full Text] [Related]
10. The use of systemic immunity adjuvants in the prophylaxis or therapy of cancer. Mathé G; Halle-Pannenko O; Bourut C; Hiu IJ Johns Hopkins Med J Suppl; 1974; 3():85-102. PubMed ID: 4154074 [No Abstract] [Full Text] [Related]
11. L2C leukemia: a model of human acute leukemia. Murphy SG; LoBuglio AF Fed Proc; 1977 Aug; 36(9):2281-5. PubMed ID: 328309 [No Abstract] [Full Text] [Related]
12. [BCG in cancer therapy--wishful thinking or the therapy of the future?]. Jungi WF Schweiz Med Wochenschr; 1976 Oct; 106(41):1389-91. PubMed ID: 795025 [No Abstract] [Full Text] [Related]
16. [Our experience in using chemo- and immunotherapy for children with acute leukemia]. Blau HI; Schultz M Probl Gematol Pereliv Krovi; 1981 Aug; 26(8):25-6. PubMed ID: 6946412 [No Abstract] [Full Text] [Related]
17. BCG immunization for the lymphoid leukemia line (LSTRA) in CDF1 mice. Chaparas SD; Chirigos M; Pearson J; Sher N Natl Cancer Inst Monogr; 1973 Dec; 39():87-8. PubMed ID: 4595328 [No Abstract] [Full Text] [Related]
18. BCG in cancer immunotherapy: experimental and clinical trials of its use in treatment of leukemia minimal and or residual disease. Mathé G; Weiner R; Pouillart P; Schwarzenberg L; Jasmin C; Schneider M; Hayat M; Amiel JL; de Vassal F; Rosenfeld C Natl Cancer Inst Monogr; 1973 Dec; 39():165-75. PubMed ID: 4595314 [No Abstract] [Full Text] [Related]
19. Modulation of the immune response by BCG: a review. Murahata RI; Mitchell MS Yale J Biol Med; 1976 Jul; 49(3):283-91. PubMed ID: 785826 [No Abstract] [Full Text] [Related]